Bal Pharma

{
  "main_header": {
    "sid": 555664,
    "name": "Bal Pharma",
    "stock_name": "Bal Pharma",
    "full_name": "Bal Pharma Ltd",
    "name_url": "stocks-analysis/bal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "91.00",
    "chg": 1.62,
    "chgp": "1.81%",
    "dir": 1,
    "prev_price": "89.38",
    "mcapval": "142.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524824,
    "symbol": "BALPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE083D01012",
    "curr_date": "Aug 10, 03:50 PM",
    "curr_time": "16:00 PM",
    "last_traded_at": "Aug 10, 03:50 PM IST",
    "bse_nse_vol": "39.54 k",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bal-pharma-555664-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bal Pharma Ltd Downgraded to Sell Amid Weak Fundamentals and Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-downgraded-to-sell-amid-weak-fundamentals-and-mixed-technical-signals-4141166",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BalPharmaLtd_mojoScore_4141166.png",
        "date": "2026-08-07 08:17:20",
        "description": "Bal Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 6 August 2026. This change reflects a combination of deteriorating technical indicators, flat financial performance, and weak long-term fundamentals, despite some attractive valuation metrics. The company’s stock price has also underperformed key benchmarks, signalling caution for investors."
      },
      {
        "title": "When is the next results date for Bal Pharma Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-bal-pharma-ltd-4140500",
        "imagepath": "",
        "date": "2026-08-06 23:18:52",
        "description": "The next results date for Bal Pharma Ltd is scheduled for 12 August 2026...."
      },
      {
        "title": "Bal Pharma Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-hold-by-marketsmojo-4139550",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BalPharmaLtd_mojoScore_4139550.png",
        "date": "2026-08-06 10:11:57",
        "description": "Bal Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bal Pharma Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-hold-by-marketsmojo-4121003",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BalPharmaLtd_mojoScore_4121003.png",
        "date": "2026-07-26 10:10:40",
        "description": "Bal Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 July 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 26 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Bal Pharma Ltd Valuation Shifts to Very Attractive Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-valuation-shifts-to-very-attractive-amid-sector-challenges-4116893",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BalPharmaLtd_valuationdot_4116893.png",
        "date": "2026-07-23 08:00:51",
        "description": "Bal Pharma Ltd has seen a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a modest decline in its share price. This change reflects improving price-to-earnings and price-to-book value ratios relative to its historical averages and peer group, signalling a potential opportunity for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Bal Pharma Gains 9.25%: Valuation Shift and Technical Upgrade Drive Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-gains-925-valuation-shift-and-technical-upgrade-drive-momentum-4107571",
        "imagepath": "",
        "date": "2026-07-18 17:01:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Jul:</strong> Stock opens at ₹79.31, modest decline amid flat Sensex</p>\n                    <p><strong>14 Jul:</strong> Mojo Grade upgraded to Hold; stock surges 14.61% to ₹90.90</p>\n                    <p><strong>15 Jul:</strong> Valuation improves amid sector volatility; stock dips 3.67% to ₹87.56</p>\n                    <p><strong>16 Jul:</strong> Minor correction with 1.38% decline to ₹86.35</p>\n                    <p><strong>17 Jul:</strong> Week closes at ₹87.05, up 0.81% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.79.68</div></d..."
      },
      {
        "title": "Bal Pharma Ltd Upgraded to Hold as Technicals and Valuation Improve",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-upgraded-to-hold-as-technicals-and-valuation-improve-4103247",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BalPharmaLtd_mojoScore_4103247.png",
        "date": "2026-07-15 08:11:59",
        "description": "Bal Pharma Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and valuation metrics despite ongoing challenges in financial performance and long-term growth. The upgrade, effective from 14 Jul 2026, is driven primarily by bullish technical trends and a more attractive valuation profile relative to its pharmaceutical peers."
      },
      {
        "title": "Bal Pharma Ltd Valuation Improves as Price Attractiveness Shifts Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-valuation-improves-as-price-attractiveness-shifts-amid-sector-challenges-4102903",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BalPharmaLtd_valuationdot_4102903.png",
        "date": "2026-07-15 08:00:32",
        "description": "Bal Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting improved price appeal relative to its historical averages and peer group. This upgrade comes amid a volatile pharmaceutical sector landscape, where the company’s micro-cap status and recent price surge have drawn investor attention despite mixed longer-term returns."
      },
      {
        "title": "Bal Pharma Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-sell-by-marketsmojo-4090710",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BalPharmaLtd_mojoScore_4090710.png",
        "date": "2026-07-06 10:10:05",
        "description": "Bal Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 July 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance."
      }
    ],
    "total": 159,
    "sid": "555664",
    "stock_news_url": "https://www.marketsmojo.com/news/bal-pharma-555664"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Considering Inter-Alia The Unaudited (Standalone And Consolidated) Financial Statements Of The Company For The First Quarter Ended 30Th June 2026 And Other General Business Matters",
      "datetime": "05-Aug-2026",
      "details": "Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of Bal Pharma Limited is scheduled to be held on Wednesday August 12 2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2026 (Q1/2026-27) and such other matters as may be considered necessary with the permission of the Chair.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 : Intimation Regarding Notice Of Postal Ballot",
      "datetime": "30-Jul-2026",
      "details": "Company Providing opportunity to shareholders to Submit their Comments on Corrigendum to the Postal ballot notice",
      "source": "BSE"
    },
    {
      "caption": "Intimation Regarding Corrigendum To The Postal Ballot Notice",
      "datetime": "23-Jul-2026",
      "details": "In Continuation of Postal Ballot Notice dated 09th July 2026 Submitting Corrigendum as integral part to the Said Notice.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bal Pharma Ltd has declared <strong>12%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bal Pharma Ltd Downgraded to Sell Amid Weak Fundamentals and Mixed Technical Signals

2026-08-07 08:17:20

Bal Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 6 August 2026. This change reflects a combination of deteriorating technical indicators, flat financial performance, and weak long-term fundamentals, despite some attractive valuation metrics. The company’s stock price has also underperformed key benchmarks, signalling caution for investors.

Read full news article

When is the next results date for Bal Pharma Ltd?

2026-08-06 23:18:52

The next results date for Bal Pharma Ltd is scheduled for 12 August 2026....

Read full news article

Bal Pharma Ltd is Rated Hold by MarketsMOJO

2026-08-06 10:11:57

Bal Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Bal Pharma Ltd is Rated Hold by MarketsMOJO

2026-07-26 10:10:40

Bal Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 July 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 26 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Bal Pharma Ltd Valuation Shifts to Very Attractive Amid Sector Challenges

2026-07-23 08:00:51

Bal Pharma Ltd has seen a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a modest decline in its share price. This change reflects improving price-to-earnings and price-to-book value ratios relative to its historical averages and peer group, signalling a potential opportunity for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Bal Pharma Gains 9.25%: Valuation Shift and Technical Upgrade Drive Momentum

2026-07-18 17:01:17

Key Events This Week

13 Jul: Stock opens at ₹79.31, modest decline amid flat Sensex

14 Jul: Mojo Grade upgraded to Hold; stock surges 14.61% to ₹90.90

15 Jul: Valuation improves amid sector volatility; stock dips 3.67% to ₹87.56

16 Jul: Minor correction with 1.38% decline to ₹86.35

17 Jul: Week closes at ₹87.05, up 0.81% on the day

Week Open

Rs.79.68

Read full news article

Bal Pharma Ltd Upgraded to Hold as Technicals and Valuation Improve

2026-07-15 08:11:59

Bal Pharma Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and valuation metrics despite ongoing challenges in financial performance and long-term growth. The upgrade, effective from 14 Jul 2026, is driven primarily by bullish technical trends and a more attractive valuation profile relative to its pharmaceutical peers.

Read full news article

Bal Pharma Ltd Valuation Improves as Price Attractiveness Shifts Amid Sector Challenges

2026-07-15 08:00:32

Bal Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting improved price appeal relative to its historical averages and peer group. This upgrade comes amid a volatile pharmaceutical sector landscape, where the company’s micro-cap status and recent price surge have drawn investor attention despite mixed longer-term returns.

Read full news article

Bal Pharma Ltd is Rated Sell by MarketsMOJO

2026-07-06 10:10:05

Bal Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 July 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance.

Read full news article

View All News